ENO1 and Alzheimer disease: Compared to the control mice, the expression of PAGM1, SYN2, Cplx2, and 1433Z were determined to be upregulated and the expression of ENO1 was determined to be downregulated in the 3xTg-AD mice treated with loganin (Figure 7A–7D).